Pharmacogenomics Focus Target pharmacogenomics and PGx testing programs as primary sales angles, highlighting Translational Software's established toolkit, CPIC/FDA/DPWG guidance, and full traceability to support labs expanding clinically actionable reporting.

Clinical Reach Leverage the large clinician impact to position value through consultative partnerships with labs and health systems seeking scalable, audit-ready pharmacogenomics reporting that improves prescribing decisions and patient safety.

Strategic Partnerships Prioritize opportunities with laboratories and telehealth/benefits platforms (such as PWN Health, Allscripts/2bPrecise networks, MedImpact) to embed PGx workflows and end-to-end testing advocacy within existing clinical programs.

Growth Momentum Capitalize on past partnerships and expansions to pursue new lab networks and regional healthcare organizations, offering integrated PGx solutions that align with current moves toward precision medicine adoption.

Technology Advantage Highlight cloud-based, auditable lab informatics and secure data provenance as differentiators to win mid-market labs seeking scalable tech stacks (AWS, HubSpot, Marketo, WordPress) and strong compliance for reporting.